BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34679258)

  • 1. Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic.
    Al-Abdulrazzaq D; Alkandari A; Alhusaini F; Alenazi N; Gujral UP; Narayan KMV; Al-Kandari H;
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3506. PubMed ID: 34679258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Severity of Presentation Signs in Children with Newly Diagnosed Type 1 Diabetes during the COVID-19 Pandemic: A Tertiary Center Experience.
    İzci Güllü E; Akin L; Gökler ME; Aydin M
    Ann Nutr Metab; 2024; 80(3):161-170. PubMed ID: 38479369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
    Hao S; Cossen K; Westbrook AL; Umpierrez GE; Vellanki P
    Endocr Pract; 2023 Oct; 29(10):754-761. PubMed ID: 37451650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.
    Alaqeel A; Aljuraibah F; Alsuhaibani M; Huneif M; Alsaheel A; Dubayee MA; Alsaedi A; Bakkar A; Alnahari A; Taha A; Alharbi K; Alanazi Y; Almadhi S; Khalifah RA
    Front Endocrinol (Lausanne); 2021; 12():669302. PubMed ID: 33868185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID-19 pandemic: Evidence from Kuwait.
    Al-Abdulrazzaq D; Albatineh AN; Khalifa D; Alrefae A; Al-Awadhi E; Alkandari A; Alhomaidah D; Cunningham SA; Al-Kandari H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3824. PubMed ID: 38837532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Diabetic Ketoacidosis in Childhood New-Onset Type 1 Diabetes With Day of Presentation in Germany.
    Kamrath C; Sindichakis M; Auzanneau M; Schmid S; Segerer H; Lahn V; Golembowsky S; Roessner-Cold D; Rauh K; Manuwald U; Holl RW
    Diabetes Care; 2024 Apr; 47(4):649-652. PubMed ID: 38128074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes: A report from a tertiary medical center in Central Pennsylvania.
    Bogale KT; Hale DE; Schaefer E; Bangalore Krishna K
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00186. PubMed ID: 33855199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic.
    Sinthuprasith P; Wejaphikul K; Puttawong D; Tang-Ngam H; Sanrattana N; Unachak K; Dejkhamron P
    J Pediatr Endocrinol Metab; 2024 Jun; 37(6):487-496. PubMed ID: 38615333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring ketoacidosis frequency and risk factors in childhood-onset type 1 diabetes: an 8-year retrospective study (2011-2018) at a tertiary paediatric hospital in Tripoli, Libya.
    Shebani MS; Khashebi RM
    J Pediatr Endocrinol Metab; 2024 Jun; 37(6):497-504. PubMed ID: 38695494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological characteristics of children diagnosed with-Type 1 diabetes during the COVID-19 pandemic.
    Margolis MG; Weizman S; Lazar L; Yakobovich-Gavan M; Tenenbaum A; Phillip M; Oron T
    Diabet Med; 2024 May; 41(5):e15250. PubMed ID: 37897235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes in pediatrics during the COVID-19 pandemic: Time from symptom onset and forms of presentation at a referral hospital.
    Andrés ME; Grimberg N; Torres F; Ferraro M; Jiménez V; Linari MA
    Arch Argent Pediatr; 2024 Aug; 122(4):e202310291. PubMed ID: 38656825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and severity of ketoacidosis in childhood-onset diabetes in Kuwait. Kuwait Diabetes Study Group.
    al Khawari M; Shaltout A; Qabazard M; Abdella N; al Moemen J; al-Mazidi Z; Mandani F; Moussa MA
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):123-8. PubMed ID: 9179467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic - The role of primary care in early diagnosis and prevention of severe diabetic decompensation.
    Pina H; Martins JD; Guerra S; Aragüés JM; Valadas C
    Prim Care Diabetes; 2023 Oct; 17(5):524-525. PubMed ID: 37353465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic.
    Azova S; Liu E; Wolfsdorf J
    Pediatr Diabetes; 2023; 2023():. PubMed ID: 38050487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmasking the escalation: a comparative analysis of diabetic ketoacidosis severity before and during the COVID-19 pandemic in a Tunisian pioneer study.
    Gorchane A; Ach T; Sahli J; Hadj Salah NB; Ben Lasfar N; Ben Abdelkrim A; Mallouli M; Bellazreg F; Hachfi W; Chadli Chaieb M; Letaief A; Ach K
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):393-398. PubMed ID: 38752587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Diabetes on the Rise: Trends in Incident Diabetes During the COVID-19 Pandemic.
    Modarelli R; Sarah S; Ramaker ME; Bolobiongo M; Benjamin R; Gumus Balikcioglu P
    J Endocr Soc; 2022 Apr; 6(4):bvac024. PubMed ID: 35265783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
    Barrett CE; Koyama AK; Alvarez P; Chow W; Lundeen EA; Perrine CG; Pavkov ME; Rolka DB; Wiltz JL; Bull-Otterson L; Gray S; Boehmer TK; Gundlapalli AV; Siegel DA; Kompaniyets L; Goodman AB; Mahon BE; Tauxe RV; Remley K; Saydah S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):59-65. PubMed ID: 35025851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the association between COVID-19 and new-onset diabetes in children, including diabetic ketoacidosis (DKA).
    Waite M; Hards K
    Evid Based Nurs; 2024 Jun; 27(3):100. PubMed ID: 37793788
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and prognosis of fulminant type 1 diabetes mellitus in The Middle East: a comparative analysis in a 5-year nationwide cohort.
    Ata F; Khan AA; Khamees I; AlKodmani S; Al-Sadi A; Yaseen KB; Muthanna B; Godwin A; Beer SF; Bashir M
    BMC Endocr Disord; 2024 Mar; 24(1):33. PubMed ID: 38462602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.